GlassScriptPhysician profile
Timothy M Manoni
NPI 1821008715
$46,187.78
in general payments reported to CMS, 2019-2025
35 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,927 · 2020: $395 · 2021: $1,307 · 2022: $4,558 · 2023: $11K · 2024: $15K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $29K · Food and Beverage: $8,756 · Travel and Lodging: $16.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $29,227.77 |
| Food and Beverage | $8,756.13 |
| Travel and Lodging | $16.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $29,658.31 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $4,206.69 | 2021-2025 | Endurant Iis, Abre, Ellipsys Vascular Access System |
| Bard Peripheral Vascular, INC. | $3,546.25 | 2019-2025 | Crosser Iq, Crosser Iq, Fluency Endovascular Stent Graft |
| Endologix LLC | $1,395.07 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Torus Stent Graft System |
| Silk Road Medical, INC. | $1,013.93 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $987.99 | 2019-2025 | Zilver Ptx, Rosen |
| Janssen Pharmaceuticals, INC | $959.84 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $740.18 | 2020-2025 | Opticross 35, Enroute Transcarotid Neuroprotection System, Eluvia |
| Lemaitre Vascular, INC. | $673.03 | 2019-2025 | Artegraft Vascular Graft, Restoreflow |
| E.R. Squibb & Sons, L.L.C. | $455.48 | 2020-2025 | Eliquis |
| Philips North America LLC | $425.23 | 2019-2024 | (Dd1) Duo Hybrid |
| Inari Medical, INC. | $379.61 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $379.09 | 2019-2025 | |
| Medtronic Vascular, INC. | $306.38 | 2019-2020 | |
| Stryker Corporation | $166.65 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $162.59 | 2021-2023 | Pulsar-18 T3 |
| Lifenet Health | $160.97 | 2025 | Theragenesis Wound Matrix |
| Tactile Systems Technology INC | $141.05 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Smith+Nephew, INC. | $95.29 | 2019-2025 | Renasys Touch |
| Merit Medical Systems INC | $43.05 | 2025 | Surfacer Inside-Out Catheter, Wrapsody Stent Graft |
| Sanara Medtech INC. | $28.10 | 2024 | Celleraterx |
| Covidien LP | $25.92 | 2019 | |
| Reprise Biomedical, INC. | $25.20 | 2023 | Miroderm, Miro3d |
| Abbott Laboratories | $25.17 | 2023 | Jeti Peripheral Catheter |
| W. L. Gore & Associates, INC. | $24.94 | 2019 | |
| Cardiovascular Systems INC. | $24.15 | 2021 | |
| Asahi Intecc USA, INC. | $20.89 | 2025 | Asahi Peripheral Vascular Wires |
| Solventum Corporation | $19.20 | 2024 | Activ.A.C. |
| Portola Pharmaceuticals, LLC | $19.10 | 2020 | |
| Bolton Medical INC | $18.79 | 2024 | Treo Abdominal Stent-Graft System |
| Paratek Pharmaceuticals, INC. | $15.76 | 2024 | Nuzyra |
| Cordis US Corp. | $15.36 | 2024 | Radial 360 |
| Ethicon US, LLC | $12.90 | 2020 | |
| Bsn Medical INC | $11.62 | 2019 | |
| Organogenesis INC. | $4.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Manoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.